| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.1 | 0.007 |